← Open Payments lookup

JEFFREY LAFFERMAN: Open Payments

NPI 1396779385 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$410 in 18 payments from 10 companies in 2025. Trend: 2023 $437 · 2024 $464 · 2025 $410

Food & beverage: $410
CompanyPaymentsAmount
ABBVIE INC.5$116
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$72
Otsuka America Pharmaceutical, Inc.2$63
Vanda Pharmaceuticals Inc.2$38
Neurocrine BioSciences, Inc.1$32
Lundbeck LLC1$24
HARMONY BIOSCIENCES LLC1$21
Takeda Pharmaceuticals U.S.A., Inc.1$17
Alkermes, Inc.1$16
E.R. Squibb & Sons, L.L.C.1$14

Products named: VRAYLAR, REXULTI, CAPLYTA, HETLIOZ, INGREZZA, WAKIX, TRINTELLIX, ARISTADA.

Industry payments across MD — which companies pay providers there.